[Effect of exogenous prostaglandins on the cardiovascular system].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D003326:Coronary Circulation / Q000187:drug effects; D004347:Drug Interactions; D011464:Epoprostenol / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011455:Prostaglandins A, Synthetic / Q000494:pharmacology; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology; D011465:Prostaglandins, Synthetic / Q000494:pharmacology* / Q000627:therapeutic use
D009712:Nucleotides, Cyclic; D011455:Prostaglandins A, Synthetic; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D011465:Prostaglandins, Synthetic; D011464:Epoprostenol
Vliianie ékzogennykh prostaglandinov na serdechno-sosudistuiu sistemu.